Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas E Stinchcombe

Showing results (11-20 of 199) with videos related to

Pageof 20
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2023
Flashback Foreword: Afatinib for the Treatment of Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung CancerThomas E Stinchcombe
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2023
Flashback Foreword: Gefitinib in Non-Small-Cell Lung Cancer: The IDEAL 1 TrialThomas E Stinchcombe
Current Treatment Options in Oncology|March 11, 2016
The Use of EGFR Tyrosine Kinase Inhibitors in EGFR Wild-Type Non-Small-Cell Lung CancerThomas E Stinchcombe
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2023
Encorafenib and Binimetinib: A New Treatment Option for Thomas E Stinchcombe
Cancer Treatment and Research|August 19, 2016
Targeted Therapies for Lung CancerThomas E Stinchcombe
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2023
Flashback Foreword: Pemetrexed and Cisplatin in MesotheliomaThomas E Stinchcombe
Translational Lung Cancer Research|March 26, 2015
INFORM; C-TONG 0805: A multicenter, double blind randomized phase III trial of maintenance gefitinib compared to placebo in advanced non-small cell lung cancerThomas E Stinchcombe
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2023
Flashback Foreword: Cisplatin/Pemetrexed in Non-Small-Cell Lung CancerThomas E Stinchcombe
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2023
Flashback Foreword: Bevacizumab + Carboplatin/Paclitaxel in NSCLCThomas E Stinchcombe
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 29, 2020
IMpower 131: The Exception to the RuleThomas E Stinchcombe
Pageof 20

Showing results (11-20 of 199) with videos related to

Sort By:
Pageof 20
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2023
Flashback Foreword: Afatinib for the Treatment of Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung CancerThomas E Stinchcombe
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2023
Flashback Foreword: Gefitinib in Non-Small-Cell Lung Cancer: The IDEAL 1 TrialThomas E Stinchcombe
Current Treatment Options in Oncology|March 11, 2016
The Use of EGFR Tyrosine Kinase Inhibitors in EGFR Wild-Type Non-Small-Cell Lung CancerThomas E Stinchcombe
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2023
Encorafenib and Binimetinib: A New Treatment Option for Thomas E Stinchcombe
Cancer Treatment and Research|August 19, 2016
Targeted Therapies for Lung CancerThomas E Stinchcombe
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2023
Flashback Foreword: Pemetrexed and Cisplatin in MesotheliomaThomas E Stinchcombe
Translational Lung Cancer Research|March 26, 2015
INFORM; C-TONG 0805: A multicenter, double blind randomized phase III trial of maintenance gefitinib compared to placebo in advanced non-small cell lung cancerThomas E Stinchcombe
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2023
Flashback Foreword: Cisplatin/Pemetrexed in Non-Small-Cell Lung CancerThomas E Stinchcombe
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2023
Flashback Foreword: Bevacizumab + Carboplatin/Paclitaxel in NSCLCThomas E Stinchcombe
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 29, 2020
IMpower 131: The Exception to the RuleThomas E Stinchcombe
Pageof 20